Navigation Links
Emerson Resources Announces CEO Retirement and Appointment of Successor
Date:5/21/2013

Norristown, PA (PRWEB) May 21, 2013

Emerson Resources Inc., a premier pharmaceutical development company, today announced that Dr. Charles Signorino, the Company’s Chief Executive Officer and Chairman of the Board, retired on April 1, 2013 after 32 years of service. As part of Emerson Resources’ planned leadership succession process, Adolfo Gomez, Emerson’s current President, has been named as Dr. Signorino’s successor.

Dr. Signorino is a recognized luminary in the pharmaceutical industry, having made a significant contribution to the field during his extensive career. He is an established expert in many aspects of tablet coating and holds 17 U.S. patents related to the area. Additionally, he is named in Who’s Who of American Scientists, has been published in numerous technical journals over the past three decades, and is a member of key industry organizations.

He joined Emerson Resources in 1981 as President and Chairman of the Board, following 20 years of service at Colorcon Inc. as Vice President and member of the Board of Directors. Dr. Signorino was elected CEO of Emerson Resources in 2002, based on his visionary leadership and notable expertise in Emerson’s core areas of focus. During his tenure at Emerson Resources, Dr. Signorino also formed CS Associates, a contract lab for coating services, in 1987.

“The entire team at Emerson Resources would like to express our gratitude to Dr. Signorino for his lifelong dedication to the field, as well as his steadfast service to the Company,” said Adolfo Gomez, President. “Dr. Signorino has set the bar very high for me as his successor. He has not only established the Company as a global name in the pharmaceutical and nutritional supplement industries, he has also inspired the Company with his strategic vision, passion for lifelong learning and strong family values.

Adolfo Gomez, a Principal of the Company with more than 20 years of industry experience, joined Emerson Resources in 2001. In his role as President, he has been responsible for managing every aspect of the business, with a specific focus on Business Development and Strategy. Mr. Gomez is credited for his instrumental role in diversifying Emerson Resources’ business model to include partnerships with industry leading organizations, as well as working very closely with Emerson’s management team to ensure adherence to the company’s core values.

In his new role as CEO, Mr. Gomez will continue implement a strategic plan that centers on three key areas of focus for the Company. These areas include:

  •     Ensuring the Company remains focused on helping clients with their drug development strategies that will allow them to bring their molecules to market as quickly and efficiently as possible.
  •     Maintaining the dynamic culture of creativity and ownership that differentiates Emerson Resources from the competition.
  •     Staying on the forefront of cutting edge technologies that allow the Company to maintain its reputation as an excellent problem solver, with pragmatic yet creative solutions.

“I am delighted to pass the opportunity to build on Emerson Resources’ history of innovation, service and success to Mr. Gomez," said Dr. Signorino. "He is a talented leader and I look forward to supporting him as he moves the Company to its next level of growth.”

About Emerson Resources
Emerson Resources’ reputation as a dependable, dynamic, flexible, and pragmatic
organization has been built on the core concepts of excellent service, superb quality and
complete client satisfaction. The Emerson mission is to deliver value-added service,
ingredients and expertise to the pharmaceutical and biotech industries.

Read the full story at http://www.prweb.com/releases/2013/5/prweb10746974.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Wiley Job Network Announces New Resources and Tools to Connect Job Seekers and Employers
2. Touch Medical Media Splits From Touch Briefings, Launches a Series of Cutting Edge, Free to Access, Educational Resources and Signs an Updated Media Partnership With ECCO, The European CanCer Organisation Representing 60,000 Oncology Professionals
3. New Informatics and Bioimaging Center combines resources, expertise from UMD, UMB
4. Walgreens Joins with Ferring Pharmaceuticals Inc. to Offer Products and Resources to Women Facing Fertility Complications from Cancer Treatment
5. Cepheid Welcomes Senior Vice President of Human Resources
6. MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer
7. Revolutionary Science Announces New Automatic and Manual Colony Counting Products
8. Nanonex Announces the Shipment and Installation of an Innovative Nanoimprint Lithography System for Fully Automated Manufacturing
9. SoundConnect Announces Microsoft Lync Release in Canada
10. GLM Displays Announces All-in-One Formulate Fusion Fabric Display Kit
11. Rhythm Announces Phase 1b Results for Ghrelin Prokinetic RM-131 for Gastroparesis in Patients with Type 1 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... City, Missouri (PRWEB) , ... May 27, 2016 , ... ... Development Manager, Turf and Ornamental Products. , In his 15-year career with PBI-Gordon, Dave ... Herbicide Product Manager, where he was integral in the development and launch of many ...
(Date:5/27/2016)... NEW YORK , May 27, 2016 ... state, but investors playing in this space know that volatility ... this morning,s featured companies on ActiveWallSt.com: Synta Pharmaceuticals Corp. (NASDAQ: ... CTIC ), Lpath Inc. (NASDAQ: LPTN ), and ... now and gain access to the technical alerts for these ...
(Date:5/26/2016)... , May 26, 2016 Q BioMed ... it will be a featured presenter at the 5th Annual ... New York City at the Grand Hyatt ... , Q BioMed Inc. CEO, is scheduled to begin at ... the company,s business strategy, recent developments and outline milestones for ...
(Date:5/26/2016)... ... 26, 2016 , ... Kinder Scientific (KinderScientific.com), a leading animal ... the Company for the future. Kinder Scientific announces restructured ownership and additional ... appointed Chairman of the Board, Curtis D. Kinghorn has been appointed CEO/President and ...
Breaking Biology Technology:
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted ... quarter of 2015 The gross margin was 49% (27) ... the operating margin was 40% (-13) Earnings per share ... operations was SEK 249.9 M (21.2) , Outlook   ... M. The operating margin for 2016 is estimated to ...
(Date:4/26/2016)... , April 27, 2016 ... the  "Global Multi-modal Biometrics Market 2016-2020"  report to ... ) , The analysts forecast the ... CAGR of 15.49% during the period 2016-2020.  ... number of sectors such as the healthcare, BFSI, ...
(Date:4/15/2016)... 15, 2016  A new partnership announced today ... underwriting decisions in a fraction of the time ... and high-value life insurance policies to consumers without ... With Force Diagnostics, rapid testing (A1C, Cotinine and ... (blood pressure, weight, pulse, BMI, and activity data) ...
Breaking Biology News(10 mins):